Cancer cells transfected with siRNAs specific for RASSF1 or CDKN1A and then treated with DETA/NO failed to inhibit cell proliferation or enhance caspase-3 activity (Figure 7C–H). The gene discussed is CDKN1A; the disease is cancer.